Deep Learning Based Dominant Index Lesion Segmentation for MR-guided Radiation Therapy of Prostate Cancer
Authors:
Josiah Simeth,
Jue Jiang,
Anton Nosov,
Andreas Wibmer,
Michael Zelefsky,
Neelam Tyagi,
Harini Veeraraghavan
Abstract:
Dose escalation radiotherapy allows increased control of prostate cancer (PCa) but requires segmentation of dominant index lesions (DIL), motivating the development of automated methods for fast, accurate, and consistent segmentation of PCa DIL. We evaluated five deep-learning networks on apparent diffusion coefficient (ADC) MRI from 500 lesions in 365 patients arising from internal training Datas…
▽ More
Dose escalation radiotherapy allows increased control of prostate cancer (PCa) but requires segmentation of dominant index lesions (DIL), motivating the development of automated methods for fast, accurate, and consistent segmentation of PCa DIL. We evaluated five deep-learning networks on apparent diffusion coefficient (ADC) MRI from 500 lesions in 365 patients arising from internal training Dataset 1 (1.5Tesla GE MR with endorectal coil), external ProstateX Dataset 2 (3Tesla Siemens MR), and internal inter-rater Dataset 3 (3Tesla Philips MR). The networks include: multiple resolution residually connected network (MRRN) and MRRN regularized in training with deep supervision (MRRN-DS), Unet, Unet++, ResUnet, and fast panoptic segmentation (FPSnet) as well as fast panoptic segmentation with smoothed labels (FPSnet-SL). Models were evaluated by volumetric DIL segmentation accuracy using Dice similarity coefficient (DSC) and detection accuracy, as a function of lesion aggressiveness, size, and location (Dataset 1 and 2), and accuracy with respect to two-raters (on Dataset 3). In general MRRN-DS more accurately segmented tumors than other methods on the testing datasets. MRRN-DS significantly outperformed ResUnet in Dataset2 (DSC of 0.54 vs. 0.44, p<0.001) and the Unet++ in Dataset3 (DSC of 0.45 vs. p=0.04). FPSnet-SL was similarly accurate as MRRN-DS in Dataset2 (p = 0.30), but MRRN-DS significantly outperformed FPSnet and FPSnet-SL in both Dataset1 (0.60 vs 0.51 [p=0.01] and 0.54 [p=0.049] respectively) and Dataset3 (0.45 vs 0.06 [p=0.002] and 0.24 [p=0.004] respectively). Finally, MRRN-DS produced slightly higher agreement with experienced radiologist than two radiologists in Dataset 3 (DSC of 0.45 vs. 0.41).
△ Less
Submitted 6 March, 2023;
originally announced March 2023.
